Production of Secretory Leucocyte Protease Inhibitor (SLPI) in Human Pancreatic β-Cells

• Autori principali: Max Nyström (Autore), Magnus Bergenfeldt (Autore), Irena Ljungcrantz (Autore), Èsa Lindeheim (Autore), Kjell Ohlsson (Autore)
• Natura: Libro
• Pubblicazione: Hindawi Limited, 1999-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Secretory leucocyte protease inhibitor (SLPI) is a potent inhibitor of granulocyte elastase and cathepsin G, and also an inhibitor of pancreatic enzymes like trypsin, chymotrypsin and pancreatic elastase. SLPI has also been shown to inhibit HIV-1 infections by blocking viral DNA synthesis. Since SLP...